CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
NCT05168423
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
67
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
CART-EGFR-IL13Ra2 Cells
Sponsor
University of Pennsylvania
Collaborators
[object Object]